TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.04M | -8.60M | -9.92M | -11.26M | -9.21M |
| Total Depreciation and Amortization | 225.00K | 248.00K | 270.00K | 267.00K | 266.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.80M | 2.07M | 1.38M | 1.85M | 2.47M |
| Change in Net Operating Assets | 1.15M | 564.00K | 367.00K | -579.00K | -1.05M |
| Cash from Operations | -4.87M | -5.72M | -7.91M | -9.73M | -7.53M |
| Capital Expenditure | -91.00K | -211.00K | -114.00K | -32.00K | -264.00K |
| Sale of Property, Plant, and Equipment | 283.00K | 523.00K | 318.00K | 170.00K | 74.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 192.00K | 312.00K | 204.00K | 138.00K | -190.00K |
| Total Debt Issued | 60.00M | -- | -- | -- | -- |
| Total Debt Repaid | -42.42M | -- | -- | -- | -- |
| Issuance of Common Stock | 11.82M | 45.00K | 0.00 | 61.00K | 42.92M |
| Repurchase of Common Stock | -4.00K | -21.00K | -3.00K | -177.00K | -11.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.55M | -- | -- | -- | -- |
| Cash from Financing | 25.85M | 24.00K | -3.00K | -116.00K | 42.91M |
| Foreign Exchange rate Adjustments | -35.00K | 104.00K | -152.00K | -134.00K | 182.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.13M | -5.28M | -7.86M | -9.84M | 35.37M |